iSpecimen Inc.
ISPC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $7,533 | $2,447 | $754 | $1,891 |
| - Cash | $2,783 | $589 | $783 | $1,878 |
| + Debt | $281 | $288 | $300 | $312 |
| Enterprise Value | $5,032 | $2,146 | $271 | $325 |
| Revenue | $107 | $713 | $1,058 | $1,476 |
| % Growth | -85.1% | -32.6% | -28.3% | – |
| Gross Profit | -$98 | $269 | $400 | $151 |
| % Margin | -91.9% | 37.7% | 37.8% | 10.3% |
| EBITDA | -$2,357 | -$615 | -$1,205 | -$5,295 |
| % Margin | -2,211.4% | -86.2% | -114% | -358.9% |
| Net Income | -$2,781 | -$1,047 | -$1,658 | -$6,047 |
| % Margin | -2,608.7% | -146.9% | -156.8% | -409.8% |
| EPS Diluted | -0.48 | -0.42 | -2.33 | -8.51 |
| % Growth | -14.3% | 82% | 72.6% | – |
| Operating Cash Flow | -$2,036 | -$192 | -$1,096 | -$3,433 |
| Capital Expenditures | $0 | -$0 | $0 | -$33 |
| Free Cash Flow | -$2,036 | -$193 | -$1,096 | -$3,466 |